IL-27 promotes the expansion of self-renewing CD8⁺ T cells in persistent viral infection.

IL-27 treatment led to an approximately twofold reduction of viral titers in the brain and a plasma titer reduction in some mice that did not reach statistical significance (Fig.

also in 111,027 other papers